Jade Biosciences Inc (JBIO) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Jade Biosciences Inc   (NASDAQ: JBIO)


Jade Biosciences Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Jade Biosciences Inc's ROI in the second quarter of 2026?
Jade Biosciences Inc recorded a cumulative net loss of $-153 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -49%.

Within the Healthcare sector 127 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 2228 to 3765.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 2009.08 % - 1919.11 % 34.4 % -81.84 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 441 297 333 180 202
Return On Investment (TTM) -49 % -51.19 % -80.61 % -160 % -624.45 %
JBIO's Overall Ranking # 3765 # 2228 # 2814 # 3290 # 3450
Seq. Investment Change TTM 23.52 % 60.2 % 150.62 % 325.3 % -
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -153 -130 -127 -101 -93

JBIO Company Profile >> Back to JBIO Roi Comparisons >> See Annual JBIO Return On Investment



Return On Investment JBIO's Ranking
Within: No.
Industry # 40
Sector # 128
Overall # 3765

Return On Investment Statistics
High Average Low
-6.72 %
-56.12 %
-185.62 %
(Mar 31 2022)   (Mar 31 2025)



  News about Jade Biosciences Inc Return on Investment ROI

Advancing the Frontier of Renal Therapy JADE101’s Promising Data Unveiled at Kidney Week 2025

October 17, 2025

: Jade Biosciences has recently unveiled noteworthy data concerning its investigative therapeutic agent, JADE101, at the American Society of Nephrology’s Annual Kidney Week 2025. This cutting-edge therapy shows potential in addressing critical unmet needs within nephrology, offering hope to countless patients suffering from kidney diseases. This report provides a detailed examination of the newly presented data, highlighting the mechanism of action, clinical efficacy, and future implications of JADE101 in the treatment landscape of chronic kidney disease (CKD).Chronic kidney disease remains a significant public health challenge, with growing prevalence and limited therapeutic options. In response to this demand, Jade Biosciences has been at the forefront of developing novel therapies aimed at altering disease progression and improving patient outcomes. At Kidney Week 2025, Jade Biosciences presented compelling new data on their leading compound, JADE101, underscoring its potential as a promising treatment modality in nephrology.





Financial Statements
Jade Biosciences Inc's II. Quarter Investments $ 441 Millions JBIO's Balance sheet
Jade Biosciences Inc's II. Quarter Income $ -56 Millions Quarterly JBIO's Income Statement
JBIO's Income by Division See JBIO's Income by Division


JBIO Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 333 77 110 128 173
Y / Y Investment Growth 335.59 % -30.24 % -14 % -26.21 % -
Net Income in Millions -127 -70 -76 -52 -23
Y / Y Net Income Growth - - - - -
Annual Return On Investment -38.23 % -91.01 % -68.87 % -40.39 % -13.29 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
JBIO's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for JBIO's Competitors
Subscribers only: Roi for Jade Biosciences Inc's Suppliers
Subscribers only: Return On Investment for JBIO's Customers

Other Ratios
JBIO's Roa JBIO's Inventory Turnover Ratio JBIO's Growth Rates JBIO's Dividend Statistics
JBIO's Profitability Ratios JBIO's Asset Turnover Ratio JBIO's Dividend Growth
JBIO's Roe JBIO's Valuation Ratios JBIO's Financial Strength Ratios JBIO's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-08T18:21:33+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.